aH5N6c on Day 22: Clinical Trials

2 completed. 2 Phase 2.

By phase and status

Phase	Trials	Status
Phase 2	2	Completed 2

Follow aH5N6c on Day 22: new trials by email Literature Review of aH5N6c on Day 22 trials Research Report on aH5N6c on Day 22

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Study to Evaluate Safety and Immunogenicity of Different Priming and Booster Regimens With Adjuvanted H5N8 and/or H5N6 Influenza Vaccine in Adults aH5N8c on Day 1, aH5N6c on Day 1, aH5N8c on Day 22 - Influenza, Human, Infections	Phase 2	Completed	Seqirus	480	2023-06-07	2024-12-13
A Study to Evaluate Safety and Immunogenicity of One or Two Booster Vaccinations With H5N6 Influenza Vaccine in Adults Primed With H5N1 Influenza Vaccine or Unprimed aH5N6c on Day 1, aH5N6c on Day 22, Placebo on Day 22 - Influenza, Human, Influenza in Birds	Phase 2	Completed	Seqirus	260	2022-07-18	2026-05-13

Conditions studied

Infections (2)  ·  Influenza, Human (2)  ·  Respiratory Tract Infections (2)  ·  Virus Diseases (2)  ·  Influenza in Birds (1)  ·  Orthomyxoviridae Infections (1)  ·  RNA Virus Infections (1)  ·  Respiratory Tract Diseases (1)

Sponsors

Seqirus (2)

Countries

United States (2)